Risk for COVID-19 hospitalization or death reduced for those who were severely or moderately immunocompromised
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent
COVID-19 Infection, Vaccination Have Little Effect on Migraine Worsening
Increased concern about migraine worsening was risk factor for perceived migraine worsening
FDA Approves Updated Novavax COVID-19 Vaccine
Updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus